Tuberculosis (TB) remains a significant global health concern, necessitating advancements in detection methods. Modern diagnostic strategies offer a more accurate, rapid, and efficient detection process, thus enhancing TB control and management.
Introduced in 2010, GeneXpert MTB/RIF revolutionized TB diagnostics. It uses real-time polymerase chain reaction (PCR) to detect Mycobacterium tuberculosis complex (MTBC) and rifampicin resistance within two hours. Its high sensitivity and specificity make it an excellent tool for diagnosing TB, especially in HIV co-infected patients and extrapulmonary TB.
Line Probe Assays (LPAs) are WHO-endorsed molecular tests that detect TB and drug resistance. They offer quick results and are particularly useful in diagnosing multi-drug resistant TB (MDR-TB). However, their reliance on cultured samples may limit their utility in resource-poor settings.
Next-Generation Sequencing (NGS) is an emerging technology in TB diagnostics. It provides comprehensive genomic information, allowing for the identification of drug resistance mutations and strain typing. Although currently expensive and technically demanding, NGS promises a future of personalized TB treatment.
Interferon-Gamma Release Assays (IGRAs) are blood tests that measure the immune response to TB antigens. They offer an advantage over traditional tuberculin skin tests by reducing false positives due to BCG vaccination or non-tuberculous mycobacteria.
Advancements in TB detection have significantly improved diagnostic accuracy and speed. However, challenges remain, including cost, technical complexity, and the need for infrastructure and trained personnel. Continued research and innovation are vital to overcoming these barriers and ensuring that these advanced diagnostics are accessible to all who need them.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation